# Investigating the Metabolic Pathways in Hormone Receptor Positive/HER2 Negative Breast Cancer

> **NCT05736367** · NA · RECRUITING · sponsor: **Rutgers, The State University of New Jersey** · enrollment: 16 (estimated)

## Conditions studied

- Breast Cancer

## Interventions

- **DRUG:** U-13C-glucose

## Key facts

- **NCT ID:** NCT05736367
- **Lead sponsor:** Rutgers, The State University of New Jersey
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-11-15
- **Primary completion:** 2026-06-30
- **Final completion:** 2028-06-30
- **Target enrollment:** 16 (ESTIMATED)
- **Last updated:** 2026-01-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05736367

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05736367, "Investigating the Metabolic Pathways in Hormone Receptor Positive/HER2 Negative Breast Cancer". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT05736367. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*